|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-02 | Enveric Biosciences Initiates IND-Enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 | CI |
| 06-02 | Enveric Biosciences Begins Genotoxicity Testing for EB-003 | MT |
| Market Cap | 4.71M 4.11M 3.8M 3.56M 6.67M 444M 6.72M 45.12M 17.48M 219M 17.69M 17.31M 760M | P/E 2024 |
-0.28x | P/E 2025 | -0.1x |
|---|---|---|---|---|---|
| Enterprise Value | 35.32K 30.8K 28.48K 26.69K 49.98K 3.33M 50.38K 338K 131K 1.64M 133K 130K 5.7M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.57M -8.35M -7.72M -7.24M -13.55M -903M -13.66M -91.67M -35.52M -445M -35.94M -35.17M -1.54B | -8.77M -7.65M -7.07M -6.63M -12.41M -827M -12.51M -83.98M -32.54M -407M -32.92M -32.22M -1.41B |
| Net Debt | -2.24M -1.95M -1.81M -1.69M -3.17M -211M -3.2M -21.46M -8.31M -104M -8.41M -8.23M -361M | -4.68M -4.08M -3.77M -3.53M -6.62M -441M -6.67M -44.78M -17.35M -217M -17.56M -17.18M -754M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















